Bayer Korea said it has entered into a strategic partnership with Chong Kun Dang to co-market Kerendia (ingredienet: finerenone), Bayer's novel treatment for chronic kidney disease (CKD) in patients with type 2 diabetes.Kerendia received approval from the Ministry of Food and Drug Safety in May 2022
Precision medicine is changing the treatment performance of many adult cancers, including lung, colon, and breast cancer. By identifying the "driver gene mutations" that cause cancer and targeting them with therapies, the cure rate is increasing. What about pediatric cancers, however?It is widely un
The Ministry of Food and Drug Safety (MFDS) plans to strengthen the control of medical narcotics by making the most of the risk management plan (RMP).Drug Safety Planning Officer Chae Kyu-han said the ministry would shore up the management of medical narcotics through RMPs and provide more safety in
Medical interns and residents are writing letters of resignation, prompted by the government’s announcement on Tuesday to increase the number of medical school enrollment quota by 2,000 from next year.These trainee doctors also protested the government's essential healthcare-enhancing policy package
Samsung Biologics has announced a collaborative venture into the development of antibody-drug conjugate (ADC) therapies by signing a new contract development organization (CDO) agreement with LegoChem Biosciences, a Korean ADC developer.Under the accord, Samsung Biologics will participate in the ess
The Ministry of Health and Welfare's announcement on Tuesday to increase medical school admissions by 2,000 students from the 2025 academic year has sparked a major backlash from doctors.This marks the most significant expansion in medical education capacity in 27 years, elevating the current quota
Led by homegrown anticancer drug Leclaza (lazertinib), Yuhan Corp. will continue its quest to become one of the top 50 global pharmaceutical companies this year. Yuhan aims to become one of the top 50 global pharmaceutical companies by 2026, its 100th founding anniversary.Yuhan Corp. CEO Cho Wook-je
The prevalence of obesity among children and adolescents has been rapidly increasing over the past decade, leading Korea to become an increasingly obese nation. Experts anticipate this trend to worsen in the future, urging the need for countermeasures.According to the “2023 Obesity Fact Sheet” publi
Huons said it has signed a technology transfer agreement with EFIL BioScience for a functional material derived from the root vegetable parsnip, which is known for its potential benefits in supporting respiratory wellness.EFIL BioScience, established in 2021, is a Korean biotech startup focusing on
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have made a discovery in the field of genetic regulation, highlighting the critical role of Alu elements in diseases such as tumor formation and neurodegenerative disorders.Alu elements, which make up about 10 percent of
Curacle announced top-line results from its U.S. phase 2a clinical trial of CU06, an oral treatment for diabetic macular edema, on Monday."In this short-term, three-month trial, we found that CU06 blocked endothelial dysfunction and improved visual acuity, with a 5.8 increase in the number of letter
Some users of spinal muscular atrophy (SMA) treatment Spinraza (nusinersen) failed to get reimbursement because their motor function was not maintained or improved after its administration.The Health Insurance Review and Assessment Service (HIRA) released the results of the recent Medical Review and
Janssen's antidepressant Spravato (esketamine) has failed to demonstrate efficacy in clinical trials in China following Japan, raising questions about its effectiveness in Koreans.The Central Pharmaceutical Review Committee under the Ministry of Food and Drug Safety (MFDS) concluded that the drugmak
Celltrion said that Rani Therapeutics has reported positive topline results from its phase 1 clinical trial of RT-111, an oral form of ustekinumab.The trial, conducted in Australia, involved 55 healthy adults and aimed to evaluate the pharmacokinetics (PK) and safety of RT-111, showcasing an impress
Chong Kun Dang said its consolidated operating profit surged by 124.4 percent on-year to 246.6 billion won ($184.7 million) in 2023, marking a record achievement thanks to its recent licensing deal with Novartis.The company's annual revenue increased by 12.2 percent to 1.6 trillion won last year, se
Daewoong Pharmaceutical said that the company achieved its highest-ever annual performance in 2023 across three key metrics -- sales, operating profit, and operating profit margin.On a standalone basis, the company reported sales of 1.2 trillion won ($900 million), an operating profit of 133.4 billi
A Korean research team has presented a method to accurately predict lung cancer by analyzing the bronchi microbiome.Chungnam National University Hospital said Monday that a research team led by Professors Jeong Jae-wook and Kang Da-hyun of the Department of Respiratory and Allergy Medicine recently
As the government prepares to announce an increase in medical school enrollment quotas before the Lunar New Year holidays, the medical community is on edge.Following an emergency meeting by the Korean Intern and Resident Association (KIRA) last Friday, the Korean Medical Association (KMA) held a boa
Neurophet and ReadyCure said they have signed a business agreement to exchange business and conduct projects related to developing an Alzheimer's disease treatment.Under the accord, Neurophet will cooperate on developing ReadyCure's upcoming dementia treatment medical device, Helaxon.Utilizing its a
Waycen, a medical AI company, said Monday that it has been certified as the “No. 7 Innovative Medical Device Software Manufacturer” by the Ministry of Food and Drug Safety (MFDS).Waycen won the certification for its continuous quality management efforts, including product development, verification,